Temporary Dental Cement

Temporary dental cement supports short-duration fixation and sealing in restorative, prosthodontic, endodontic, and implant-related procedures. Its clinical role is to maintain restoration stability, protect prepared tooth structure, and enable later retrieval when treatment planning or tissue healing requires reversibility. Demand is shaped by procedure volumes, dental access, clinician preferences, material handling, biocompatibility, and the shift toward digitally planned workflows.

The landscape is changing as clinicians balance retention with retrievability, moisture tolerance, working time, cleanup, radiopacity, and compatibility with definitive luting materials. Zinc oxide-based, resin-based, glass-ionomer, and calcium hydroxide-containing formulations serve different indications, so product selection increasingly depends on restoration type, substrate, occlusal conditions, and whether eugenol could interfere with subsequent resin bonding. Premeasured capsules, automix delivery, improved viscosity control, and clearer application protocols are helping reduce preparation variability and chairside waste.

Artificial intelligence is influencing temporary cement workflows mainly through decision support rather than autonomous material selection. Imaging and digital treatment-planning systems can help classify restorations, abutments, margins, and occlusal conditions, while practice software can support documentation, inventory management, and appointment sequencing. AI-generated recommendations still require clinician validation because cement performance depends on isolation, surface treatment, preparation geometry, removal timing, and the compatibility of the temporary material with the planned definitive restoration.

North America combines advanced restorative workflows with strong emphasis on product documentation, infection control, and predictable chairside handling. Europe reflects harmonized regulatory expectations alongside varied reimbursement and clinical practice across countries. Asia-Pacific includes technologically advanced dental systems and rapidly expanding access, with demand influenced by urbanization, private dental investment, and local manufacturing. Latin America is shaped by uneven access, price sensitivity, and growth of private restorative care. The Middle East shows concentrated investment in specialty and cosmetic dentistry, while Africa presents substantial differences in infrastructure, clinician availability, supply reliability, and affordability across markets.

ASEAN markets reflect diverse regulatory systems, import dependencies, and rapidly developing private dental networks, making training and supply continuity important. BRICS members span large and heterogeneous dental systems, with adoption influenced by domestic production, public-private care structures, and affordability. The European Union benefits from coordinated regulatory principles but retains national differences in reimbursement and procurement. G7 markets generally emphasize evidence, workflow efficiency, and advanced restorative techniques. GCC countries show strong private-sector and specialist-care activity, while NATO members combine varied healthcare models with established dental education, procurement, and regulatory infrastructures.

Australia and Canada are influenced by broad professional standards, private dental delivery, and geographically dispersed access. Brazil and Mexico combine substantial private dental activity with marked regional variation in affordability and distribution. China and India have large, diverse care systems where urban specialty clinics coexist with uneven access elsewhere. France, Germany, Italy, and Spain operate within European regulatory expectations while differing in reimbursement, procurement, and practice organization. Japan and South Korea emphasize precision, conservative treatment, and technologically enabled workflows. Russia’s market conditions are shaped by domestic supply considerations and evolving access to imported products. The United Kingdom and United States show strong use of specialist and digitally integrated restorative workflows, with procurement and clinical protocols varying by practice setting.

Industry leaders should segment formulations by indication rather than treating temporary cement as a single-use category. Product development should prioritize predictable retention, easy retrieval, cleanup, moisture tolerance, radiopacity, and compatibility with definitive bonding procedures. Clear indication-specific instructions, comparative clinical evidence, and training materials can reduce misuse. Supply strategies should include qualified regional distribution, resilient access to key raw materials, and packaging suited to different practice volumes. Digital decision aids may improve consistency, but they should be designed as transparent, clinician-supervised tools with documented limitations.

This executive summary is based on a structured qualitative assessment of temporary dental cement applications, formulation characteristics, clinical workflows, regulatory considerations, dental-care infrastructure, and technology adoption. Findings are synthesized across the specified regions, country groups, and countries using publicly available professional, scientific, regulatory, and healthcare-system evidence. The assessment emphasizes verifiable directional factors and avoids unsupported numerical claims. Because clinical practice and regulatory conditions change, product decisions should be validated against current local requirements, professional guidance, and manufacturer instructions for use.

Temporary dental cement remains an important enabling material for staged and provisional care. The strongest opportunities are tied to formulations and delivery systems that make temporary fixation predictable while preserving safe removal and dependable subsequent treatment. Regional and country differences will continue to reflect access, regulation, clinical training, and procurement structures. Leaders that combine indication-specific performance, robust evidence, reliable supply, and clinician-centered digital support will be better positioned to meet evolving restorative workflows.